全球病毒清除服务市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

预计到 2032 年，全球病毒清除服务市场的市场规模将从 2023 年的 8.5809 亿美元达到近 30.3049 亿美元，2024-2032 年研究期间复合年增长率为 15.05%。

病毒清除服务是指生物製药公司透过去除或灭活病毒和其他潜在污染物来确保生物製品安全的过程。该服务涉及严格的测试和验证程序，以证明层析、过滤和灭活技术等病毒清除方法的有效性。病毒清除服务对于开发和製造生物製剂、疫苗和基因治疗产品以降低病毒传播给患者的风险至关重要。

市场动态

病毒感染、疫情和新出现的病原体的日益流行，加上对生物製药产品（包括单株抗体、单株和重组蛋白）的需求不断增长，更加需要强有力的病毒清除验证研究，以确保生物製药产品的安全性和有效性。病毒清除服务透过评估製造过程中病毒灭活和去除步骤的有效性，在评估生物製剂的病毒安全性方面发挥关键作用，推动其在生物製药行业的采用。此外，欧洲药品管理局（EMA）和美国食品药物管理局（FDA）等卫生当局发布的严格监管要求和指南要求实施病毒清除研究，作为生物製药产品监管审批流程的一部分，推动了市场需求。此外，生物製药生产过程（包括细胞培养、发酵和纯化）日益复杂和多样化，为有效解决病毒污染风险带来了挑战，推动了对病毒清除服务提供者提供的专业知识和测试服务的需求，进一步推动了市场成长。

此外，由于资源限制、上市时间压力以及独立第三方验证的需要，生物製药公司外包病毒清除测试和验证研究的趋势不断增长，为合约研究组织（CRO）和测试实验室提供全面的病毒清除服务，推动市场扩张。病毒安全法规的不断发展、分析技术的进步以及生物加工技术的新兴趋势预计将推动市场的进一步创新和投资，支持全球医疗保健市场安全有效的生物製药产品的开发和商业化。然而，不断变化的监管要求、技术进步以及来自内部病毒清除能力的竞争可能会挑战市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球病毒清除服务市场的每个细分市场进行了包容性评估。病毒清除服务产业的成长和趋势为本研究提供了整体方法。

市场区隔

病毒清除服务市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依方法

• 病毒清除
• 病毒灭活（化学、辐射、其他）

按申请

• 重组蛋白
• 组织和血液衍生产品
• 疫苗
• 其他的

按最终用户

• 生物製药
• 合约研究组织
• 学术研究机构
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲病毒清除服务市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。病毒清除服务市场的主要参与者包括Texcell、Eurofins Scientific SE、Charles River Laboratories International, Inc.、Merck KGaA、WuXi AppTec、Clean Cells、Vironova Biosafety AB。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：病毒清除服务 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 市场吸引力分析方法
  • 市场吸引力分析：依应用分类
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球病毒清除服务市场分析：依方法

• 依方法概述
• 历史和预测数据
• 方法分析
• 病毒清除
• 病毒灭活（化学、辐射、其他）

第 6 章：全球病毒清除服务市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 重组蛋白
• 组织和血液衍生产品
• 疫苗
• 其他的

第 7 章：全球病毒清除服务市场分析：依最终使用者分类

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 生物製药
• 合约研究组织
• 学术研究机构
• 其他的

第 8 章：全球病毒清除服务市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：病毒清除服务公司的竞争格局

• 病毒清除服务市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Texcell
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Eurofins Scientific SE
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Charles River Laboratories International Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck KGaA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• WuXi AppTec
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Clean Cells
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Vironova Biosafety AB
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Viral Clearance Service Market is presumed to reach the market size of nearly USD 3030.49 Million by 2032 from USD 858.09 Million in 2023 with a CAGR of 15.05% under the study period 2024 - 2032.

Viral clearance service refers to a process conducted by biopharmaceutical companies to ensure the safety of biological products by removing or inactivating viruses and other potential contaminants. This service involves rigorous testing and validation procedures to demonstrate the effectiveness of viral clearance methods such as chromatography, filtration, and inactivation techniques. Viral clearance services are critical in developing and manufacturing biologics, vaccines, and gene therapy products to mitigate the risk of viral transmission to patients.

MARKET DYNAMICS

The increasing prevalence of viral infections, outbreaks, and emerging pathogens, coupled with the growing need for biopharmaceutical products, including monoclonal antibodies, monoclonaland recombinant proteins, has heightened the need for robust viral clearance validation research to guarantee the safety and efficacy of biopharmaceutical products for human use. Viral clearance services play a critical role in assessing the viral safety of biologics by evaluating the effectiveness of viral inactivation and removal steps during manufacturing processes, driving their adoption across the biopharmaceutical industry. Additionally, stringent regulatory requirements and guidelines issued by health authorities such as the EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) mandate the implementation of viral clearance studies as part of the regulatory approval process for biopharmaceutical products, driving market demand. Moreover, increasing complexity and diversity in biopharmaceutical production processes, including cell culture, fermentation, and purification, have created challenges in effectively addressing viral contamination risks, driving the need for specialized expertise and testing services offered by viral clearance service providers, further fuelling market growth.

Furthermore, the growing trend towards outsourcing viral clearance testing and validation studies by biopharmaceutical companies, driven by resource constraints, time-to-market pressures, and the need for independent third-party validation, has created opportunities for contract research organizations (CROs) and testing laboratories to offer comprehensive viral clearance services, driving market expansion. The evolving landscape of viral safety regulations, advancements in analytical techniques, and emerging trends in bioprocessing technology are expected to drive further innovation and investment in the market, supporting the development and commercialization of safe and effective biopharmaceutical products for global healthcare markets. However, evolving regulatory requirements, technological advancements, and competition from in-house viral clearance capabilities may challenge the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of viral clearance service. The growth and trends of viral clearance service industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the viral clearance service market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

• Viral Removal
• Viral Inactivation (Chemical, Radiation, Others)

By Application

• Recombinant Proteins
• Tissue And Blood-Derived Products
• Vaccines
• Others

By End-User

• Biopharmaceuticals
• Contract Research Organizations
• Academic Research Institutes
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Viral Clearance Service market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Viral Clearance Service market include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA, WuXi AppTec, Clean Cells, Vironova Biosafety AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . VIRAL CLEARANCE SERVICE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Method
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY METHOD

• 5.1 Overview by Method
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Method
• 5.4 Viral Removal Historic and Forecast Sales by Regions
• 5.5 Viral Inactivation (Chemical, Radiation, Others) Historic and Forecast Sales by Regions

6 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Recombinant Proteins Historic and Forecast Sales by Regions
• 6.5 Tissue and Blood-derived Products Historic and Forecast Sales by Regions
• 6.6 Vaccines Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Biopharmaceuticals Historic and Forecast Sales by Regions
• 7.5 Contract Research Organizations Historic and Forecast Sales by Regions
• 7.6 Academic Research Institutes Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE VIRAL CLEARANCE SERVICE COMPANIES

• 9.1. Viral Clearance Service Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF VIRAL CLEARANCE SERVICE INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Texcell
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Eurofins Scientific SE
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Charles River Laboratories International Inc.
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Merck KGaA
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. WuXi AppTec
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Clean Cells
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Vironova Biosafety AB
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Method (USD MN)
• Viral Removal Market Sales by Geography (USD MN)
• Viral Inactivation (Chemical, Radiation, Others) Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Recombinant Proteins Market Sales by Geography (USD MN)
• Tissue and Blood-derived Products Market Sales by Geography (USD MN)
• Vaccines Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Biopharmaceuticals Market Sales by Geography (USD MN)
• Contract Research Organizations Market Sales by Geography (USD MN)
• Academic Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Viral Clearance Service Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Viral Clearance Service Report
• Market Research Process
• Market Research Methodology
• Global Viral Clearance Service Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Method
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Method (USD MN)
• Viral Removal Market Sales by Geography (USD MN)
• Viral Inactivation (Chemical, Radiation, Others) Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Recombinant Proteins Market Sales by Geography (USD MN)
• Tissue and Blood-derived Products Market Sales by Geography (USD MN)
• Vaccines Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Biopharmaceuticals Market Sales by Geography (USD MN)
• Contract Research Organizations Market Sales by Geography (USD MN)
• Academic Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.